Moneycontrol PRO
Upcoming Webinar:Watch a panel of experts discuss: Challenges of continuously evolving regulation for Cryptocurrency, on 7th July at 3pm. Register Now
you are here: HomeNewsIndia

Infosys Foundation donates Rs 100 crore for COVID-19 relief

The Foundation said it contributed half of this commitment (Rs 50 crore) to the PM CARES Fund.

March 30, 2020 / 10:04 PM IST

Infosys Foundation, the philanthropic and CSR arm of Infosys, on Monday announced that it is committing Rs 100 crore to support efforts towards fighting COVID-19 in the country.

The Foundation said it contributed half of this commitment (Rs 50 crore) to the PM CARES Fund.

This sum would primarily be utilised to expand hospital capacity for treatment and enable hospital stays for COVID-19 patients, especially ones belonging to the economically weaker sections of society. Also, the amount would be used to provide ventilators, testing kits, and Personal Protective Equipment like masks, and other protective gear for frontline healthcare workers; and to ensure better access to food and nutrition for the underprivileged.

Over the last two weeks, Infosys Foundation said in a statement it has announced support for creation of an exclusive hospital in Bengaluru for COVID-19 patients.

It has also enabled the acquisition of medical and PPE equipment for multiple military and government hospitals across the country.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

The Foundation is also supporting various NGOs that provide food and hygiene kits to thousands of people in need, the statement said.

All our efforts will be targeted towards ensuring that the relief material reaches the people who need it the most, whether it is a patient who cannot afford treatment, our healthcare personnel, or daily wage workers whose livelihood has been severely impacted, said chairperson of Infosys Foundation Sudha Murty said.
first published: Mar 30, 2020 09:58 pm
ISO 27001 - BSI Assurance Mark